Artesunate Injection (Leonate 30) contains Artesunate 30 mg per vial and is indicated for the treatment of severe malaria, particularly caused by Plasmodium falciparum. It is widely recommended by the World Health Organization (WHO) as the first-line injectable therapy for severe malaria in both adults and children.

Artesunate is a water-soluble derivative of artemisinin that acts quickly to reduce high parasite loads, bringing rapid relief from severe symptoms such as high fever, convulsions, and coma. Treatment with Leonate 30 is typically followed by a complete oral antimalarial course to ensure full recovery and to prevent recurrence.

Key Benefits:

• Fast-Acting Therapy: Quickly reduces parasite levels in severe malaria cases.
• Effective Strength: Contains Artesunate 30 mg per vial.
• WHO-Preferred Treatment: Recommended globally as first-line therapy for severe malaria.
• Safe for All Ages: Suitable for both adults and children under medical supervision.

How to Use:

Artesunate Injection should only be administered by a healthcare professional. The injection can be given intravenously (IV) or intramuscularly (IM), with dosing based on body weight. Treatment must always be followed by a full oral antimalarial course once the patient can tolerate oral medication.